BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 115504)

  • 1. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Production of monospecific type A botulinum toxin and antiserum using a column chromatographic method].
    Marchev N; Marcheva D
    Vet Med Nauki; 1982; 19(1):57-63. PubMed ID: 6810534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of neurotoxin and hemagglutinin from Clostridium botulinum A and characterization of its neurotoxin].
    Vinogradova ID; Uvarova RN; Ivanov KK; Kazdobina IS; Bulatova TI
    Biokhimiia; 1983 May; 48(5):788-96. PubMed ID: 6409167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular structure and immunochemical properties of highly purified hemagglutinin from Clostridium botulinum type A].
    Ivanova LG; Blagoveshchenskiĭ VA; Vinogradova ID; Kolesnikova VA; Ugriumova GA
    Biokhimiia; 1983 Sep; 48(9):1548-54. PubMed ID: 6414537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production of a homogeneous Cl. botulinum type B neurotoxin].
    Saprykina TP; Kliucheva VV; Blagoveshchenskiĭ VA; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):86-91. PubMed ID: 6778041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of Clostridium botuliunum type F progenitor toxin.
    Oishi I; Sakaguchi G
    Appl Microbiol; 1974 Dec; 28(6):923-8. PubMed ID: 4615636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 2002 Feb; 291(1):154-7. PubMed ID: 11829476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amino acid composition of major components of Cl. botulinum toxin of type B].
    Kliucheva VV; Saprykina TP; Dolgikh MS; Blagoveshchenskiĭ VA
    Vopr Med Khim; 1982; 28(5):29-33. PubMed ID: 6758340
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The partial purification of Clostridium perfringens beta toxin.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1975 Sep; 42(3):91-8. PubMed ID: 172828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.